Company SanBio Company Limited OTC Markets
Equities
SNBOY
US7995731004
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.81 USD | -48.72% | -.--% | -.--% |
19/03 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
19/03 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 27/13/27 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Administrative Officer | - | - | |
Naoki Tsukahara
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 01/13/01 |
Keita Mori
CEO | Chief Executive Officer | 56 | 27/13/27 |
Toru Kawanishi
CHM | Chairman | 56 | 27/13/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 68,630,002 | 48,833,177 ( 71.15 %) | 278 ( 0.000405 %) | 71.15 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SANBIO COMPANY LIMITED 0.00% | 200 | 0.00% | 527 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.88% | 115B | |
+12.47% | 106B | |
-4.26% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.17% | 17.56B | |
-40.50% | 17.32B | |
+6.50% | 14.03B | |
+31.27% | 12.13B |
- Stock Market
- Equities
- 4592 Stock
- SNBOY Stock
- Company SanBio Company Limited